BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8761587)

  • 1. Rapid in vitro test for determination of anti-amoebic activity.
    Mukhopadhyay RM; Chaudhuri SK
    Trans R Soc Trop Med Hyg; 1996; 90(2):189-91. PubMed ID: 8761587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rabeprazole inhibits several functions of Entamoeba histolytica related with its virulence.
    Martínez-Pérez Y; Nequiz-Avendaño M; García-Torres I; Gudiño-Zayas ME; López-Velázquez G; Enríquez-Flores S; Mendoza E; Saavedra E; Pérez-Tamayo R; León-Avila G; Olivos-García A
    Parasitol Res; 2020 Oct; 119(10):3491-3502. PubMed ID: 32886229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of pH on the amoebicidal activity of systemically active amoebicides against axenic Entamoeba histolytica.
    Dutta GP; Narain L
    Indian J Exp Biol; 1978 Jul; 16(7):838-40. PubMed ID: 29834
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro comparative evaluation of metronidazole and other anti-amoebic drugs against Entamoeba histolytica.
    Grewal MS
    Indian J Med Res; 1968 May; 56(5):646-53. PubMed ID: 4301549
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative in vitro activity of mefloquine, diloxanide furoate and other conventionally used amoebicides against entamoeba histolytica.
    Osisanya JO
    East Afr Med J; 1986 Apr; 63(4):263-8. PubMed ID: 2874011
    [No Abstract]   [Full Text] [Related]  

  • 6. A novel plate assay method for amoebicides.
    Youssef KA
    Experientia; 1964 Aug; 20(8):463-4. PubMed ID: 4285486
    [No Abstract]   [Full Text] [Related]  

  • 7. Amoebicidal in vitro activity shown by some metronidazole analogues: biological response-reduction potential correlation.
    Campos ME; Meraz M; Sánchez H; Salgado-Zamora H
    Pharm Res; 1995 Apr; 12(4):630-3. PubMed ID: 7597003
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro studies on the sensitivity of local Entamoeba histolytica to anti-amoebic drugs.
    Chintana T; Sucharit P; Mahakittikun V; Siripanth C; Suphadtanaphongs W
    Southeast Asian J Trop Med Public Health; 1986 Dec; 17(4):591-4. PubMed ID: 2883732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The presence of antiamoebic constituents in psyllium husk.
    Zaman V; Manzoor SM; Zaki M; Aziz N; Gilani AU
    Phytother Res; 2002 Feb; 16(1):78-9. PubMed ID: 11807972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rapid colorimetric assay with the tetrazolium salt MTT and phenazine methosulfate (PMS) for viability of Entamoeba histolytica.
    Cedillo-Rivera R; Ramírez A; Muñoz O
    Arch Med Res; 1992; 23(2):59-61. PubMed ID: 1285086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3'-deoxyribonucleosides and their derivatives as anti-amoebic agents.
    Ghosal S; KrishnaPrasad BN; Khanna M; Dwivedi AK; Singh S; Kumar A; Katti SB
    Int J Pharm; 2000 Jan; 194(1):15-20. PubMed ID: 10601681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some plant extracts and their anti-amoebic effect.
    Galal EE; el-Raggal MH; Khalifa W
    J Egypt Med Assoc; 1965; 48():Suppl:161-8. PubMed ID: 4289290
    [No Abstract]   [Full Text] [Related]  

  • 13. Susceptibility testing of Entamoeba histolytica.
    Cedeño JR; Krogstad DJ
    J Infect Dis; 1983 Dec; 148(6):1090-5. PubMed ID: 6140291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo inhibition of reduced thiol compounds from Entamoeba histolytica HK9 by phenothiazines and related tricyclic drugs.
    Ondarza RN; Iturbe A; Hernández E; Tamayo EM; Hurtado G
    Arch Med Res; 2000; 31(4 Suppl):S12-6. PubMed ID: 11070205
    [No Abstract]   [Full Text] [Related]  

  • 15. The anti-amoebic activity of some medicinal plants used by AIDS patients in southern Thailand.
    Sawangjaroen N; Phongpaichit S; Subhadhirasakul S; Visutthi M; Srisuwan N; Thammapalerd N
    Parasitol Res; 2006 May; 98(6):588-92. PubMed ID: 16447069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyunsaturated fatty acids induce polarized submembranous F-actin aggregates and kill Entamoeba histolytica.
    Manna D; Grewal JS; Sarkar B; Maiti S; Lohia A
    Cytoskeleton (Hoboken); 2013 May; 70(5):260-8. PubMed ID: 23568815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viability studies of pure carbon- and nitrogen-doped nanotubes with Entamoeba histolytica: from amoebicidal to biocompatible structures.
    Elías AL; Carrero-Sánchez JC; Terrones H; Endo M; Laclette JP; Terrones M
    Small; 2007 Oct; 3(10):1723-9. PubMed ID: 17849378
    [No Abstract]   [Full Text] [Related]  

  • 18. Growth inhibition and actin aggregate formation of Entamoeba histolytica by jasplakinolide.
    Makioka A; Kumagai M; Ohtomo H; Kobayashi S; Takeuchi T
    Arch Med Res; 2000; 31(4 Suppl):S145-6. PubMed ID: 11070259
    [No Abstract]   [Full Text] [Related]  

  • 19. The nitroblue tetrazolium (NBT) reduction of Entamoeba histolytica during endocytosis of E. coli and homologous antibodies.
    Kettis AA; Jarstrand C; Urban T
    Arch Invest Med (Mex); 1982; 13 Suppl 3():261-4. PubMed ID: 6295318
    [No Abstract]   [Full Text] [Related]  

  • 20. A morphodynamic live study of the interaction of metronidazole with E. histolytica trophozoites using acridine orange.
    Silva Gómez A; Hernández Jauregui P; Luna Alcántara J; Gómez Conde E
    Arch Med Res; 1997; 28 Spec No():302-3. PubMed ID: 9033110
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.